Syngene International Ltd

Company Profile

Syngene International Ltd had its IPO on under the ticker symbol SYNGENE.

The company operates in the Healthcare sector and Biotechnology & Medical Research industry. Syngene International Ltd has a staff strength of 0 employees.

Stock update

Shares of Syngene International Ltd opened at ₹840 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹828 - ₹858.35, and closed at ₹833.05.

This is a -0.73% slip from the previous day's closing price.

A total volume of 43,450 shares were traded at the close of the day’s session.

In the last one week, shares of Syngene International Ltd have increased by +4.87%.

Syngene International Ltd's Key Ratios

Syngene International Ltd has a market cap of ₹278.80 billion, indicating a price to book ratio of 7.1761 and a price to sales ratio of 8.6378.

In the last 12-months Syngene International Ltd’s revenue was ₹0 with a gross profit of ₹13.89 billion and an EBITDA of ₹0. The EBITDA ratio measures Syngene International Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Syngene International Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 1361.76%.

In Q1, Syngene International Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Syngene International Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

69.6861

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Syngene International Ltd’s profitability.

Syngene International Ltd stock is trading at a EV to sales ratio of 8.6006 and a EV to EBITDA ratio of 25.8982. Its price to sales ratio in the trailing 12-months stood at 8.6378.

Syngene International Ltd stock pays annual dividends of ₹0.5 per share, indicating a yield of 0.07% and a payout ratio of 7.07%.

Balance sheet and cash flow metrics

Total Assets

₹58.31 billion

Total Liabilities

₹11.88 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

7.07%

Syngene International Ltd ended 2025 with ₹58.31 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹58.31 billion while shareholder equity stood at ₹36.18 billion.

Syngene International Ltd ended 2025 with ₹0 in deferred long-term liabilities, ₹11.88 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹895.00 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹4.89 billion.

Syngene International Ltd’s total current assets stands at ₹24.25 billion while long-term investments were ₹0 and short-term investments were ₹13.22 billion. Its net receivables were ₹5.29 billion compared to accounts payable of ₹2.58 billion and inventory worth ₹3.33 billion.

In 2025, Syngene International Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Syngene International Ltd paid ₹0.07 in dividends in 2025.

Other key metrics

Current Trading Price

₹833.05

52-Week High

₹718.9

52-Week Low

₹511.0446

Analyst Target Price

₹

Syngene International Ltd stock is currently trading at ₹833.05 per share. It touched a 52-week high of ₹718.9 and a 52-week low of ₹718.9. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹793.23 and 200-day moving average was ₹668.66 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.